Transvaginal mesh bellwether trial scheduled
There is a new development in transvaginal mesh litigation. A significant trial is scheduled to begin in March. As of January 2015, more than 68,000
There is a new development in transvaginal mesh litigation. A significant trial is scheduled to begin in March. As of January 2015, more than 68,000
The respected medical journal JAMA Internal Medicine published a report Feb. 9 citing instances in which the U.S. Food and Drug Administration uncovered “misconduct” in
It is possible that the “complex design” of duodenoscopes may make them hard to clean, to disinfect, and to sterilize, thus infection-prone. That assessment is
First the U.S. Food and Drug Administration limited a certain antifungal drug’s use, and now an advocacy group has called for its removal in oral
Reporting that it contains an antidepressant, the U.S. Food and Drug Administration since Feb. 28 has been urging consumers “not to purchase or use” a
As if the alleged birth defects risk is not enough, a British medical journal published a case study suggesting that hepatitis may be related to
The study of sexual dysfunction linked to the use of the male pattern hair loss drug Propecia has been spreading globally, according to the growing
The U.S. Food and Drug Administration on Jan. 8 approved another diabetes drug. One should hope that patients and their physicians will not be blindsided
Reaffirming the link between taking too much acetaminophen and developing liver disease, the U.S. Food and Drug Administration on Jan. 14 escalated its recommendations on
Litigants in Lipitor product liability lawsuits, precisely the type of people we fight for here at Reich & Binstock, may see their cases transferred to
There are 344 pending Mirena IUD lawsuits centralized before the U.S. District Court for the Southern District of New York, the multidistrict litigation court, or
The experienced attorneys at Reich & Binstock represent clients in metal-on-metal hip implant lawsuits whose experiences demonstrate the futility of presumably good intentions. Recently, medical
Testosterone treatments are suspect. The U.S. Food and Drug Administration announced Jan. 31 that it has been investigating the risk of stroke, heart attack and
Effexor and Zoloft are not in the same pharmacological class of antidepressants. Nevertheless, they share a distinction in the eyes of the law. The manufacturer
The Journal of Child and Adolescent Psychopharmacology in its December 2012 issue revealed a study that examined males ages 10-20 who were taking the Johnson
Prescription drugs are not the only drugs that can be marketed despite their increased risks of harm to anyone who uses them. The U.S. Food
The U.S. Food and Drug Administration announced in January 2014 that there was something amiss about topiramate, which has been marketed as the antiepileptic Topamax.
The advocacy group Public Citizen on Feb. 25 petitioned the U.S. Food and Drug Administration to require a black box warning on testosterone products. The
Reportedly, Boehringer Ingelheim, the maker of the blood thinner Pradaxa, had two sets of data about the safety of its drug, concealing from the U.S.
The U.S. Judicial Panel on Multidistrict Litigation in February centralized Lipitor lawsuits filed in federal court. One judge will oversee consolidated pre-trial proceedings for those
There is never a fee unless we recover on your behalf.
Additionally, clients are not obligated to pay expenses if a recovery is not made.
4265 San Felipe, # 1000
Houston, TX 77027
Houston Law Office Map
Toll Free: 800-622-7271
Phone: 713-622-7271
Fax: 713-623-8724